Show simple item record

dc.contributor.authorPudjiastuti, Pratiwi
dc.contributor.authorSumarsih, Sri
dc.contributor.authorArwati, Heny
dc.contributor.authorAmalina, Ilma
dc.contributor.authorFanani, Much. Z.
dc.contributor.authorUtomo, Edi P.
dc.contributor.authorFitri, Loeki E.
dc.contributor.authorNugraha, Ari Satia
dc.contributor.authorLie, Wilford
dc.contributor.authorPyne, Stephen G.
dc.date.accessioned2016-12-14T02:53:42Z
dc.date.available2016-12-14T02:53:42Z
dc.date.issued2016-12-14
dc.identifier.issn0975-7384
dc.identifier.urihttp://repository.unej.ac.id/handle/123456789/78361
dc.description.abstractOne of the mechanism actions of antimalarial drugsis by an inhibiting on the enzyme dihydrofolate reductase (DHFR), an enzyme target antifolate drug. Epi-croomine and croomine , are alkaloids isolated from Stemonatuberosa showed DHFR inhibition with K i of 61.14 and 100.59 µM and K values of30.68 and 27.06 µM at 10 ppm. The IC 50 M to the DHFR of croomine and pyrimethamine were 5.29 and 7.71 µM, respectively. Tuberostemonine is not active to the enzyme. The kinetic analysis showed that both epi-croomine and croomine competitively inhibited to the human DHFR recombinant. The molecular modeling of the compounds to the human DHFR was estimate depi-croomine and croomine’s binding free energy of -6.66 and -7.60 kcal/mol. The docking showed that both epi-croomine and croomine could possibly form hydrogen bonds with the amino acid residue of theAla9, which residues on the active site of the enzyme.en_US
dc.language.isoenen_US
dc.subjectmalariaen_US
dc.subjectepi-croomineen_US
dc.subjectcroomineen_US
dc.subjectDHFRen_US
dc.subjectStemonatuberosaen_US
dc.titleEpi-croomine and croomine from Stemona tuberosa antimalarial drug for inhibiting dihydrofolate reductase (DHFR) activity and their molecular modelingen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record